News - Medical and health professional investment - VC and PE investment business - Shenzhen Efung Investment Management Co. Ltd.

发布时间: 2026 - 01 - 14

Efung Capital Honored on Rongzhong 2025 Annual China Equity Investment Ranking | Fenix Glory

On January 14, 2026, the Rongzhong 2025 Annual China Equity Investment Ranking was officially unveiled. Fenix Capital was named to the "Rongzhong 2025 Annual Top 100 Chinese Venture Capital Institutions," and Efung Capital CEO Zhu Pai was recognized as a "Rongzhong 2025 Outstanding Chinese Investor."Leveraging its proprietary database, BridgeData, combined with questionnaire collection, research interviews, and comprehensive data validation, Rongzhong Research conducted an overall assessment in consideration of market and industry development trends.Looking ahead, Efung Cap...

浏览次数：0

查看详情>>

发布时间: 2025 - 12 - 31

Anchoring Innovation, Winning the Future: Efung Capital's 2025 Journey

2025: China's Pharmaceutical Industry Reaches a Global Tipping PointThe Economist recently noted that the "source" of global innovation is shifting, and global life sciences are entering a clear "China Moment." China's standing in the global life sciences ecosystem is rapidly rising, and global capital is repricing China. This may not only mark the takeoff point for China's biopharmaceutical industry but also propel China from the later stages of the industrial civilization toward the frontier of the life sciences civilization.In this historic process, Efung Cap...

浏览次数：0

查看详情>>

发布时间: 2025 - 12 - 30

Monthly Health Read | December 2025

On December 26, the National Venture Capital Guidance Fund was officially launched in Beijing. The three regional funds—the Beijing-Tianjin-Hebei Venture Capital Guidance Fund, the Yangtze River Delta Venture Capital Guidance Fund, and the Greater Bay Area Venture Capital Guidance Fund—formally signed agreements with the first batch of 49 sub-funds and 27 project representatives. As one of the first batch of signatories, Efung Capital signed the agreement in Beijing, safeguarding the life and health industry.In the same month, Efung's portfolio companies demonstrated vibrant momentum, achi...

浏览次数：1

查看详情>>

发布时间: 2025 - 12 - 29

Efung Capital Named to Zero2IPO Annual Ranking: Top 30 Chinese Healthcare Investment Institutions

Today, the 25th China Equity Investment Series Rankings, initiated by the Zero2IPO Research Center under Zero2IPO Holdings, were officially announced. Efung Capital has been named to the Top 30 Chinese Healthcare Investment Institutions list for multiple consecutive years!Since 2001, Zero2IPO Research Center has been publishing annual rankings of China's equity investment industry for 24 consecutive years. Adhering to rigorous scientific research methodologies and a fair, impartial ranking approach, these rankings aim to provide a sound evaluation and benchmarking system for China's eq...

浏览次数：0

查看详情>>